543 followers
氟哌啶醇、利培酮、帕利哌酮和阿立哌唑长效形式: 339 名(2.5%)、308 名(2.2%)、52 名(0.4%)和 48 名(0.4%)患者的 PAP(表 1)。总的来说,长效药物构成了研究人群中 747 名(5.4%)患者药物处方。
氟哌啶醇、利培酮、帕利哌酮和阿立哌唑长效形式: 339 名(2.5%)、308 名(2.2%)、52 名(0.4%)和 48 名(0.4%)患者的 PAP(表 1)。总的来说,长效药物构成了研究人群中 747 名(5.4%)患者药物处方。
RT @FrontPsychiatry: New Research: Antipsychotic prescribing practices in real-life (APPREAL study): Findings from the French National Heal…
New Research: Antipsychotic prescribing practices in real-life (APPREAL study): Findings from the French National Healthcare System Database (2007–2017): Background Antipsychotics are used in a large variety of psychiatric and neurological… https://t.co/g